[{"id":"2b1be91c-a18a-4404-a539-c7f329a044ec","acronym":"","url":"https://clinicaltrials.gov/study/NCT04883125","created_at":"2021-05-12T11:53:34.575Z","updated_at":"2024-07-02T16:36:30.407Z","phase":"Phase 2","brief_title":"Value of Using Pioglitazone in Chronic Myeloid Leukemia Treatment","source_id_and_acronym":"NCT04883125","lead_sponsor":"Mansoura University","biomarkers":" ABL1 • BCR • EPAS1 • CITED2","pipe":"","alterations":" ","tags":["ABL1 • BCR • EPAS1 • CITED2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e imatinib"],"overall_status":"Completed","enrollment":" Enrollment 90","initiation":"Initiation: 01/01/2018","start_date":" 01/01/2018","primary_txt":" Primary completion: 04/15/2021","primary_completion_date":" 04/15/2021","study_txt":" Completion: 04/15/2021","study_completion_date":" 04/15/2021","last_update_posted":"2021-05-12"}]